Visit Accolade's booth at space #801 to experience how Accolade empowers employers and health plans to deliver healthcare and benefits that drive real outcomes and lower costs. Please join CEO Rajeev Singh at the "The New Shape of Work" discussion about transforming health plan benefits for the

Accolade adds WellRight's holistic, flexible employee well-being platform to the Accolade partner ecosystem which supports HR teams by consolidating and managing benefits and driving employee engagement with them SEATTLE , Oct. 12, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), a healthcare provider

Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million  Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based care Launched Accolade One and

-Personalized Healthcare is focused on human relationships and personalization using data to enable value-based care. -Accolade also announces two new healthcare solutions -- Accolade One and Accolade Care -- for employers, their members and families. SEATTLE , Sept.

Accolade executives to make announcement during the opening keynotes at Evolve21, the company's annual customer event. SEATTLE , Sept. 20, 2021 /PRNewswire/ -- WHAT:             Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare

SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2022 financial results on Thursday, October 7, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m.

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: Morgan Stanley Virtual Global Healthcare Conference including a fireside chat

SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:00 a.m.

Fiscal first quarter 2022 revenue of $59.5 million, a 66% increase compared to fiscal first quarter 2021 revenue of $35.9 million Company raises guidance for fiscal year 2022 to $300 million - $305 million, a 78% increase at the midpoint compared to fiscal year 2021 revenue of $170.4 million,

SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market closes.